STARTUP PROFILE

Bottneuro

COUNTRY
Switzerland
FOUNDED
2021
CATEGORY
Neuromodulation
Developing a personalized, non-invasive transcranial electrical stimulation system for home-based treatment support in cognitive and neurological disorders.
Visit website →
Neurofounders Insights
$   Funding   -
Seed
MODALITY
tDCS/tES
FORM FACTOR
Headset/cap
INTERFACE DEPTH
Non-invasive
INDICATION
Dementia/impairment
TARGET USER
Patients
REGULATORY STAGE
Investigational
Bottneuro is differentiated by its MRI-individualized, 3D-printed electrode montage approach to home-based tES, offering a level of stimulation personalization that generic consumer tDCS devices do not attempt. As a University of Basel spin-off with Swiss and UK device registration, it sits in a narrow segment between clinical-grade neuromodulation and consumer brain stimulation products.
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
Bottneuro
No items found.